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Introduction
The role of IR in treatment of diabetic foot disease and
Peripheral Arterial Disease (PAD) has been growing very
rapidly. It is now widely recognized that endovascular
treatment can play a crucial role in prevention of ampu-
tation in diabetic patients. It is important that this role is
also recognized by those who are the primary caretakers of
patients with diabetes. Internationally, the International
Working Group on the Diabetic Foot (IWGDF) plays an
important role in establishing the evidence for endovas-
cular treatment. The IWGDF, which was founded in 1996,
is a non-profit organization with independent funding. The
aim of the IWGDF is to create awareness of the disease and
to improve the management and prevention of the diabetic
foot. One of the main tasks of the IWGDF is to create
evidence-based guidelines on the diagnosis, prognosis, and
management of peripheral artery disease in patients with
foot ulcers [1]. These guidelines are updated every 4 years.
In 2015, there was a new update on PAD (www.iwgdf.org).
For those interventional radiologists who want to be
involved in the treatment of diabetes and PAD, it is very
important to be aware of these guidelines and, moreover, to
be part of the local clinical program implementing these
guidelines. Diagnosis, prognosis, and management are very
closely related and should all be part of IR knowledge, as it
is not possible anymore to only perform the endovascular
part as a stand-alone intervention. It is of course the
technical part of the intervention that will be the specific
role of the interventionist, but being part of a multidisci-
plinary team is mandatory for the best outcome. The evi-
dence-based systemic reviews, as performed by the
IWGDF every 4 years, result in a list of recommendations
which are approved at the general assembly at the inter-
national meeting which is also held every 4 years. This
year the meeting was in The Hague. The recommendations
are accompanied by 2 remarks, based on the GRADE scale
classification and the quality of the evidence for this rec-
ommendation. The recommendations are divided over 3
domains: diagnosis, prognosis, and treatment.
Diagnosis
1. Examine a patient with diabetes annually for the
presence of peripheral artery disease (PAD); this
should include, at a minimum, taking a history and
palpating foot pulses (GRADE recommendation:
strong; quality of evidence: low).
2. Evaluate a patient with diabetes and a foot ulcer for the
presence of PAD. Determine, as part of this examina-
tion, ankle or pedal Doppler arterial waveforms;
measure both ankle systolic pressure and systolic
ankle brachial index (ABI) (Strong; Low).
3. We recommend the use of bedside non-invasive tests
to exclude PAD. No single modality has been shown to
be optimal. Measuring ABI (with\0.9 considered as
abnormal) is useful for the detection of PAD. Tests
that largely exclude PAD are the presence of
ABI[ 0.9–1.3, toe brachial index (TBI)[0.75, and
the presence of a triphasic pedal Doppler arterial wave
forms (Strong; Low).
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Prognosis
4. In patients with a foot ulcer in diabetes and PAD, no
specific symptoms or signs of PAD reliably predict
healing of the ulcer. However, one of the following
simple bedside tests should be used to inform the
patient and healthcare professional about the healing
potential of the ulcer. Any of the following findings
increases the pre-test probability of healing by at least
25 %: a skin perfusion pressure C40 mmHg; a toe
pressure C30 mmHg; or a TcPO2 C25 mmHg
(Strong; Moderate).
5. Consider urgent vascular imaging and revasculariza-
tion in patients with a foot ulcer in diabetes where the
toe pressure is\30 mmHg or the TcPO2\25 mmHG
(Strong; Low).
6. Consider vascular imaging and revascularization in all
patients with a foot ulcer in diabetes and PAD,
irrespective of the results of bedside tests, when the
ulcer does not improve within 6 weeks despite optimal
management (Strong; Low).
7. Diabetic microangiopathy should not be considered to
be the cause of poor wound healing in patients with a
foot ulcer (Strong; Low).
8. In patients with a non-healing ulcer with either an
ankle pressure \50 mmHG or ABI\ 0.50, consider
urgent vascular imaging and revascularization (Strong;
Moderate).
Ad 4–6. It is important to discuss these criteria in the
multidisciplinary team. It is known that these parameters
for treatment can be very unreliable and often a diabetic
foot can be at risk at much higher ABI, toe pressure, or
TcPO2 [2, 3]. The clinical situation should always prevail
over these measurements. Being part of a multidisciplinary
team will also in this situation be a condition sine qua non.
Treatment
9. Color Doppler ultrasound, CT angiography, MR
angiography, or intra-arterial digital subtraction
angiography can each be used to obtain anatomical
information when revascularization is being consid-
ered. The entire lower extremity arterial circulation
should be evaluated, with detailed visualization of
below-the-knee and pedal arteries (Strong; Low).
10. The aim of revascularization is to restore direct flow
to at least one of the foot arteries, preferably the
artery that supplies the anatomical region of the
wound, with the aim of achieving a minimum skin
perfusion pressure C40 mmHg; a toe pressure
C30 mmHg; or a TcPO2 C25 mmHg (Strong; Low).
11. A center treating patients with a foot ulcer in diabetes
should have the expertise in and rapid access to
facilities necessary to diagnose and treat PAD; both
endovascular techniques and bypass surgery should
be available (Strong; Low).
12. There is inadequate evidence to establish which
revascularization technique (endo or bypass) is supe-
rior and decisions should be made in a multidisci-
plinary team on a number of individual factors, such
as morphological distribution of PAD, availability of
autogenous vein, patient co-morbidities, and local
expertise (Strong; Low).
13. After a revascularization procedure for a foot ulcer in
diabetes, the patient should be treated by a multidis-
ciplinary team as part of a comprehensive care plan
(Strong; Low).
14. Patients with signs of PAD and a foot infection are at
particularly high risk for major limb amputation and
require emergency treatment (Strong; Moderate).
15. Avoid revascularization in patients in whom, from
the patient perspective, the risk–benefit ratio for the
probability of success is unfavorable (Strong; Low).
Ad. 9 The role of the interventional radiologist is to
advise on further diagnostic imaging in case PAD is sus-
pected and there is the clinical need for treatment.
If further diagnostic imaging is needed, the most cost-
effective way is to perform Color Doppler ultrasound
imaging. This technique is very reliable but also operator
dependent [4, 5]. Alternatively both CTA and MRA can be
advised. A recent systemic review and meta-analysis
showed that both computed tomography and contrast-en-
hanced magnetic resonance angiography can evaluate
arteries in peripheral arterial disease. CTA and CE-MRA
have been shown to be accurate. Regarding the diagnostic
performances in critical limb ischemia they are not dif-
ferent. CTA and CE-MRA can distinguish confidently
between high-grade stenoses and occlusions. Often, a
separate imaging technique of tibial arteries by CE-MRA is
preferred [6]. The alternative way to extend the diagnosis is
by combining diagnosis and treatment in one session by
direct use of angiography. With a good clinical team and
good work-up, the latter is certainly an important option to
consider.
Ad 10. Although the evidence for the angiosome theory
is confusing and not very strong, the guideline suggests
that, if possible, the vessel to the angiosome or direct
revascularization should be the first choice, especially in
diabetic patients [7, 8].
Ad 11–12. Neither bypass nor endovascular surgery can
claim superiority in outcome based on the current evi-
dence. In the 2011 IWGDF guideline it read that there is
not enough evidence to make a choice between bypass
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surgery and endovascular treatment. Here again the mul-
tidisciplinary team plays a crucial role. Topics for discus-
sion in the team are morphological distribution of PAD,
availability of autogenous vein, patient co-morbidities, and
local expertise. For the interventional radiologists, exper-
tise and maintaining expertise is a very important factor.
The latter can only be obtained if every IR group has only a
limited number of clinically dedicated and trained IRs for
the treatment of diabetic foot disease. Local and interna-
tional training programs and accreditation- and outcome-
based assessments can increase the level of expertise and
IR quality.
New Endovascular Technologies
Although the new IWGDF guideline and recommendations
do not state anything about new endovascular technologies,
from an IR perspective these innovations are very impor-
tant. Unfortunately, many of the current (case) series
describing the results of new drug-eluting technologies,
like drug-eluting balloons, and drug-coated stents are of
poor scientific quality. Many are at high risk of bias with
confounding by indication and no attempts being made to
adequately adjust for ulcer duration or severity of disease.
Many studies, often performed with full control of the
sponsoring pharmaceutical company, are dominating the
data pool for a systematic review. A recent systematic
review comparing all these new technologies could only
show some small benefits for proxy endpoints like patency,
TLR, and binary restenosis, but no clinical benefit
regarding wound healing or prevention of amputation [9].
All of the published data on these new technologies also
come from patient groups where diabetes and atheroscle-
rosis are mixed. Currently, simple PTA with optional
bailout stenting still remains the technique of choice. High-
quality randomized studies are very much needed here.
In Conclusion
Interventional radiology plays a crucial role in the treat-
ment of diabetic foot disease. It is however essential for
any IR in this field to be fully clinically dedicated and to be
part of a multidisciplinary team. Also obtaining and
maintaining personal expertise is very important. The latter
could be expressed in national centers of excellence with
well-defined criteria. It is important to stay closely con-
nected to new endovascular developments but never to
forget the principle of evidence-based medicine. It is to be
expected that diabetic foot disease, and the cost related,
will further increase, so preparing for the future with
dedicated training programs and manpower is important.
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